Taha Nasser

Expression of Transforming Growth Factor Alpha and Their Receptor (EGFR) in Thyroid Carcinoma and Benign Patients

K. Ghali, Taha Nasser, H. Mousa, 2020, University of Thi-Qar Journal of Medicine.

Alemtuzumab-Induced Thyroid Dysfunction Exhibits Distinctive Clinical and Immunological Features

A. Coles, Joanne L. Jones, C. Dayan, 2018, The Journal of clinical endocrinology and metabolism.

Longitudinal Characterization of Autoantibodies to the Thyrotropin Receptor (TRAb) During Alemtuzumab Therapy: Evidence that TRAb May Precede Thyroid Dysfunction by Many Years.

P. Taylor, M. Ludgate, C. Dayan, 2018, Thyroid : official journal of the American Thyroid Association.

Expression of Transforming Growth Factorα and Epidermal Growth Factor Receptor in Thyroid Carcinoma

K. Ghali, Taha Nasser, H. Mousa, 2017 .

Relationship between TGF-α and its Receptor EGFR Expression with Clinicopathological Variables in Thyroid Carcinoma

K. Ghali, Taha Nasser, H. Mousa, 2017 .

Longitudinal characterization of autoantibodies to the thyrotropin receptor (TRAb) 1 during alemtuzumab therapy; evidence that TRAb may precede thyroid dysfunction 2 by many years. 3

M. Ludgate, M. Draman, Taha Nasser, 2022 .